363 related articles for article (PubMed ID: 18571641)
1. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Takahashi E; Katayama M; Niimi K; Itakura C
Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
[TBL] [Abstract][Full Text] [Related]
2. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
Andreasen JT; Redrobe JP
Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
[TBL] [Abstract][Full Text] [Related]
3. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
4. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
Egashira N; Matsuda T; Koushi E; Higashihara F; Mishima K; Chidori S; Hasebe N; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 Jul; 589(1-3):117-21. PubMed ID: 18565508
[TBL] [Abstract][Full Text] [Related]
5. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
Flores-Serrano AG; Vila-Luna ML; Álvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL; Pineda JC
Pharmacol Biochem Behav; 2013 Sep; 110():89-97. PubMed ID: 23769836
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
Sarkisyan G; Roberts AJ; Hedlund PB
Behav Brain Res; 2010 May; 209(1):99-108. PubMed ID: 20097233
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
Chenu F; Guiard BP; Bourin M; Gardier AM
Behav Brain Res; 2006 Sep; 172(2):256-63. PubMed ID: 16806519
[TBL] [Abstract][Full Text] [Related]
9. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
Millan MJ; Dekeyne A
Int J Neuropsychopharmacol; 2007 Oct; 10(5):579-93. PubMed ID: 17076935
[TBL] [Abstract][Full Text] [Related]
11. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
[TBL] [Abstract][Full Text] [Related]
12. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
Kleijn J; Cremers TI; Hofland CM; Westerink BH
Neurosci Res; 2011 Jul; 70(3):334-7. PubMed ID: 21420449
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Hallbäck I; Hägg S; Eriksson AC; Whiss PA
Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
[TBL] [Abstract][Full Text] [Related]
15. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.
Ulak G; Mutlu O; Akar FY; Komsuoğlu FI; Tanyeri P; Erden BF
Pharmacol Biochem Behav; 2008 Oct; 90(4):563-8. PubMed ID: 18565575
[TBL] [Abstract][Full Text] [Related]
16. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Redrobe JP; Bourin M
Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
[TBL] [Abstract][Full Text] [Related]
18. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
[TBL] [Abstract][Full Text] [Related]
19. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.
Szewczyk B; Poleszak E; Wlaź P; Wróbel A; Blicharska E; Cichy A; Dybała M; Siwek A; Pomierny-Chamioło L; Piotrowska A; Brański P; Pilc A; Nowak G
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):323-9. PubMed ID: 19150479
[TBL] [Abstract][Full Text] [Related]
20. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
Bourin M; Chenu F; Prica C; Hascoët M
Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]